New Innovation in CAR T-Cells Paves Way for Less Toxic Therapy Against Multiple Myeloma
University of Maryland School of MedicineUniversity of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the likelihood of toxic side effects from this innovative cancer treatment.